62 related articles for article (PubMed ID: 15196310)
1. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.
García-Fernández M; Castilla-Cortázar I; Díaz-Sanchez M; Navarro I; Puche JE; Castilla A; Casares AD; Clavijo E; González-Barón S
BMC Gastroenterol; 2005 Mar; 5():7. PubMed ID: 15745444
[TBL] [Abstract][Full Text] [Related]
2. Little effects of insulin-like Growth Factor-I on testicular atrophy induced by hypoxia.
Diez-Caballero F; Castilla-Cortázar I; Garcia-Fernandez M; Puche JE; Diaz-Sanchez M; Casares AD; Aliaga-Montilla MA; Rodriguez-Borrajo C; Gonzalez-Barón S
BMC Urol; 2006 Feb; 6():4. PubMed ID: 16504030
[TBL] [Abstract][Full Text] [Related]
3. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.
Mehtani R; Premkumar M; Garg S; Kajal K; Kulkarni AV; Duseja AK; Dhiman RK; De A; Verma N; Taneja S; Rathi S; Singh V; Chakma J; Soni SL; Kakkar A; Kapila AT; Ahuja CK; Divyaveer S; Praharaj D
J Clin Exp Hepatol; 2023; 13(6):977-988. PubMed ID: 37975059
[TBL] [Abstract][Full Text] [Related]
4. Is insulin-like growth factor-1 involved in Parkinson's disease development?
Castilla-Cortázar I; Aguirre GA; Femat-Roldán G; Martín-Estal I; Espinosa L
J Transl Med; 2020 Feb; 18(1):70. PubMed ID: 32046737
[TBL] [Abstract][Full Text] [Related]
5. Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats.
Qiu X; Wei X; Guan H; Su H; Gong J; Fang K; Zou X; Dong H; Xu L; Lu F
Evid Based Complement Alternat Med; 2018; 2018():3248521. PubMed ID: 30302116
[TBL] [Abstract][Full Text] [Related]
6. Changes of Intestinal Functions in Liver Cirrhosis.
Fukui H; Wiest R
Inflamm Intest Dis; 2016 Apr; 1(1):24-40. PubMed ID: 29922655
[TBL] [Abstract][Full Text] [Related]
7. Experimental approach to IGF-1 therapy in CCl
Morales-Garza LA; Puche JE; Aguirre GA; Muñoz Ú; García-Magariño M; De la Garza RG; Castilla-Cortazar I
J Transl Med; 2017 May; 15(1):96. PubMed ID: 28472963
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment.
de la Garza RG; Morales-Garza LA; Martin-Estal I; Castilla-Cortazar I
J Clin Med Res; 2017 Apr; 9(4):233-247. PubMed ID: 28270882
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.
Lara-Diaz VJ; Castilla-Cortazar I; Martín-Estal I; García-Magariño M; Aguirre GA; Puche JE; de la Garza RG; Morales LA; Muñoz U
J Physiol Biochem; 2017 May; 73(2):245-258. PubMed ID: 28124277
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 deficiency and metabolic syndrome.
Aguirre GA; De Ita JR; de la Garza RG; Castilla-Cortazar I
J Transl Med; 2016 Jan; 14():3. PubMed ID: 26733412
[TBL] [Abstract][Full Text] [Related]
11. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand.
Guerra-Menéndez L; Sádaba MC; Puche JE; Lavandera JL; de Castro LF; de Gortázar AR; Castilla-Cortázar I
J Transl Med; 2013 Oct; 11():271. PubMed ID: 24161214
[TBL] [Abstract][Full Text] [Related]
12. Human conditions of insulin-like growth factor-I (IGF-I) deficiency.
Puche JE; Castilla-Cortázar I
J Transl Med; 2012 Nov; 10():224. PubMed ID: 23148873
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats.
Castilla-Cortázar I; García-Fernández M; Delgado G; Puche JE; Sierra I; Barhoum R; González-Barón S
J Transl Med; 2011 Jul; 9():103. PubMed ID: 21733157
[TBL] [Abstract][Full Text] [Related]
14. Contribution of gut bacteria to liver pathobiology.
Son G; Kremer M; Hines IN
Gastroenterol Res Pract; 2010; 2010():. PubMed ID: 20706692
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
[TBL] [Abstract][Full Text] [Related]
16. Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I.
Castilla-Cortázar I; Pascual M; Urdaneta E; Pardo J; Puche JE; Vivas B; Díaz-Casares A; García M; Díaz-Sánchez M; Varela-Nieto I; Castilla A; González-Barón S
BMC Gastroenterol; 2004 Jun; 4():12. PubMed ID: 15196310
[TBL] [Abstract][Full Text] [Related]
17. Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I.
Pascual M; Castilla-Cortazar I; Urdaneta E; Quiroga J; Garcia M; Picardi A; Prieto J
Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G319-24. PubMed ID: 10915640
[TBL] [Abstract][Full Text] [Related]
18. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I.
Castilla-Cortazar I; Prieto J; Urdaneta E; Pascual M; Nuñez M; Zudaire E; Garcia M; Quiroga J; Santidrian S
Gastroenterology; 1997 Oct; 113(4):1180-7. PubMed ID: 9322513
[TBL] [Abstract][Full Text] [Related]
19. Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats.
Castilla-Cortázar I; Picardi A; Tosar A; Ainzúa J; Urdaneta E; García M; Pascual M; Quiroga J; Prieto J
Am J Physiol; 1999 Jan; 276(1):G37-42. PubMed ID: 9886976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]